Heart rehab gets smarter: machine learning tailors exercise to your nerves
NCT ID NCT07288840
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to improve exercise prescription in cardiac rehabilitation by using machine learning to analyze data from the autonomic nervous system. Researchers will enroll 90 patients with coronary artery disease or non-ischemic heart failure. They will measure nerve activity and other biomarkers to create a personalized exercise plan, potentially making rehab safer and more effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- personalized exercise prescription based on autonomic assessment
- What this could lead to
- If successful, this could lead to more effective and safer exercise plans for people in cardiac rehabilitation, improving heart health outcomes.
- What could go wrong
- This is a small, early-stage study focused on developing a method, not testing a treatment. The approach may not prove better than standard care or may be too complex for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients diagnosed with non-ischemic heart failure with reduced ejection fraction (NIHFrEF) or stable coronary artery disease without heart failure (CADnonHF), consecutively enrolled in the Cardiac Rehabilitation Program at Centro Hospitalar de Leiria, and undergoing comprehensive autonomic and metabolic assessment."
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with Coronary artery disease and no heart failure criteria * Patients with non ischaemic heart failure and reduced left ventricle ejection fraction Exclusion Criteria: * patients with ongoing acute coronary syndrome * patients with ongoing acute decompensated heart failure * Severe valvular heart disease that might confound the relationship between exercise and autonomic function. * Severe arrhythmias (e.g., sustained ventricular tachycardia, atrial fibrillation with a rapid ventricular rate) that are symptomatic or untreated * Severe uncontrolled hypertension (e.g., systolic BP \> 180 mmHg or diastolic BP \> 110 mmHg) * Active infectious diseases or other significant acute medical illnesses (e.g., sepsis, active malignancy, acute kidney injury) * Pregnancy or lactation (to ensure safety during exercise interventions) * Significant cognitive impairment or mental illness (e.g., dementia, schizophrenia) that would impair the ability to follow exercise protocols or understand study instructions * nability to comply with study procedures due to any reason (e.g., language barriers, lack of informed consent) * Chronically immunocompromised states (e.g., HIV with CD4 count \< 200 cells/µL or on immunosuppressive therapy) * Presence of significant comorbidities such as advanced chronic obstructive pulmonary disease (COPD), kidney disease (e.g., stage 4-5 chronic kidney disease), or uncontrolled diabetes that would make exercise unsafe or confound the study outcomes * Critical limb ischemia, or severely symptomatic peripheral artery disease or claudication limiting functional capacity and response to exercise * Advanced chronic kidney disease (stage 4 or 5), due to contraindications with exercise * Severe anemia (hemoglobin \< 8 g/dL) or other blood disorders that affect exercise capacity * Inability to tolerate exercise due to other comorbidities or debility * individuals with known autonomic neuropathy (such as poorly controlled diabetes or neurodegenerative disorders) Specific Exclusion Criteria for Coronary Artery Disease (CAD) without Heart Failure Group: * Left ventricular ejection fraction (LVEF) \< 50% * Clinical/echocardiographic criteria of heart failure with oreserved ejection fraction. Specific Exclusion Criteria for Non-Ischemic Heart Failure with Reduced LVEF Group: * Ischemic heart disease or previous myocardial infarction * LVEF \> 40% * End-stage heart failure (e.g., patients on a heart transplant list, those with imminent need for mechanical circulatory support like LVAD). * Severe fluid overload that cannot be corrected
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autonomic nervous system imbalance are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
ICVS - Life and Health Sciences Research Institute, Minho University Medical School
Braga, Minho, 4710-057, Portugal
-
ciTechCare - Center for Innovative Care and Health Technology
Leiria, Leiria District, 2414-016, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could monthly texts and automatic risk scores stop heart attacks before they start?
- Can a nurse and a neighbor help tame chronic disease?
- Two eggs a day put to the test for heart health
- A soft patch that watches your heart beat in real time
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?